| Customization: | Available |
|---|---|
| Type: | IVD Reagent |
| Sample Type Test: | Blood |
|
Still deciding? Get samples of US$ 100/Piece
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
The product is used for the determination of high density lipoprotein subcomponent (HDL-2B) in human serum in vitro.
Combined with the microfluidic chip analyzer independently developed by ABIOM, the conventional blood lipids in human serum can be accurately separated, and 5 subcomponents (HDL2, HDL3, etc.) can be obtained. Cumulative evidence suggests that larger HDL2 provides a major protective effect, while HDL-2B is an important cardiovascular protective factor that prevents atherosclerotic plaque formation.
| Cardiovascular diseases are still the "number one killer" of mankind and a serious threat to people's health. |
| According to the Report on ""Cardiovascular Health and Disease", there are 330 million cardiovascular patients in China, and more than two out of every five deaths are attributed to cardiovascular diseases. However, more than half of the patients with sudden cardiovascular disease had normal blood lipid test results, and there was no means of early risk prediction and effective treatment evaluation. |
| Early intervention of cardiovascular risk factors has become an important goal of human health management. |
| Recent studies have found that the composition of high-density lipoprotein (HDL) subcomponents is associated with anti-atherosclerosis, coronary heart disease and other cardiovascular diseases. The level of HDL in the blood is not a good indicator of lipoprotein-associated atherosclerosis. |
| Detection of HDL subclass composition in patients with hyperlipidemia is of great significance for elucidating the mechanism and risk of cardiovascular diseases. |
){kind=link}